Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Change in Account Payables: 2010-2024

Historic Change in Account Payables for CorMedix (CRMD) over the last 12 years, with Dec 2024 value amounting to -$2.6 million.

  • CorMedix's Change in Account Payables rose 424.80% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year increase of 397.19%. This contributed to the annual value of -$2.6 million for FY2024, which is 223.20% down from last year.
  • Latest data reveals that CorMedix reported Change in Account Payables of -$2.6 million as of FY2024, which was down 223.20% from $2.1 million recorded in FY2023.
  • CorMedix's Change in Account Payables' 5-year high stood at $2.1 million during FY2023, with a 5-year trough of -$2.6 million in FY2024.
  • In the last 3 years, CorMedix's Change in Account Payables had a median value of -$6,566 in 2022 and averaged -$162,859.
  • In the last 5 years, CorMedix's Change in Account Payables surged by 31,739.95% in 2023 and then plummeted by 223.20% in 2024.
  • Yearly analysis of 3 years shows CorMedix's Change in Account Payables stood at -$6,566 in 2022, then spiked by 31,739.95% to $2.1 million in 2023, then crashed by 223.20% to -$2.6 million in 2024.